Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia

NewsGuard 100/100 Score

Resveratrol, a polyphenolic compound, is synthesized in several plants and possesses beneficial biological effects, which include anti-oxidant, anti-inflammatory and anti-carcinogenic properties. Resveratrol exhibits neuroprotective effects in models of many diseases, such as cerebral ischemia, Huntington's disease, Parkinson's disease and Alzheimer's disease.

However, there is a lack of data evaluating the effect of resveratrol in vascular dementia. Dr Boai Zhang and team from the First Affiliated Hospital, Zhengzhou University found that resveratrol improved learning and memory ability in vascular dementia rats, decreased malonyldialdehyde levels, and increased superoxide dismutase activity and glutathione levels in the hippocampus and cerebral cortex of vascular dementia rats. Their results, published in the Neural Regeneration Research (Vol. 8, No. 22, 2013), demonstrate that resveratrol improves learning and memory ability, reduce oxidative stress following vascular dementia in rats, and provide an experimental basis and theoretical evidence for the clinical use of resveratrol in the treatment of vascular dementia.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Risks of antipsychotic use in dementia extend beyond previous alerts, study shows